Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?

Area of Science:

• Reproductive Immunology
• Obstetrics
• Hematology

Background:

• Adverse pregnancy outcomes often lack clear diagnostic criteria, particularly in cases suggestive of obstetric antiphospholipid syndrome (OAPS).
• Non-criteria OAPS (NC-OAPS) encompasses women not meeting international classification criteria but exhibiting specific pregnancy losses or antiphospholipid antibody profiles.
• Heterogeneity in NC-OAPS necessitates standardized nomenclature and further research.

Purpose of the Study:

• To critically analyze evidence supporting NC-OAPS diagnosis.
• To categorize distinct subsets within NC-OAPS.
• To evaluate the impact of various treatment strategies on NC-OAPS outcomes.

Main Methods:

• Review of retrospective and prospective cohort studies.
• Analysis of clinical and laboratory data related to pregnancy outcomes and antiphospholipid antibodies.
• Critical evaluation of scientific evidence regarding treatment efficacy.

Main Results:

• Evidence supports potential benefits of antithrombotic, anticoagulant, and immunomodulatory agents for NC-OAPS.
• Specific subsets of NC-OAPS show promise with certain treatments.
• Robustness and nuances of current scientific evidence require careful consideration.

Conclusions:

• NC-OAPS represents a recognized clinical entity requiring further investigation.
• Treatment strategies may improve outcomes, but consensus on diagnostic criteria and protocols is lacking.
• Ongoing research is crucial to refine understanding and management of NC-OAPS.